Jalra Europäische Union - Deutsch - EMA (European Medicines Agency)

jalra

novartis europharm limited - vildagliptin - diabetes mellitus, typ 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 und 5. 1 für verfügbare daten zu verschiedenen kombinationen).

Eucreas Europäische Union - Deutsch - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, metformin-hydrochlorid - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Vildagliptin Zentiva 50 mg Tabletten Vildagliptin Zentiva 50 mg Tabletten Schweiz - Deutsch - Swissmedic (Swiss Agency for Therapeutic Products)

vildagliptin zentiva 50 mg tabletten vildagliptin zentiva 50 mg tabletten

helvepharm ag - vildagliptinum - vildagliptin zentiva 50 mg tabletten - vildagliptinum 50 mg, lactosum 136 mg, carboxymethylamylum natricum a corresp. natrium 0.336 - 0.504 mg, magnesii stearas, pro compresso. - diabetes mellitus typ 2 - synthetika